Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1519.780
- +5.739+0.38%
Close Jan 3 16:00 ET
1526.082High1512.197Low
1514.436Open1514.041Pre Close46.90MVolume5Rise56.31P/E (Static)3.51BTurnover--Flatline0.44%Turnover Ratio1.43TMarket Cap2Fall1.32TFloat Cap
Constituent Stocks: 7Top Rising: VKTX+4.30%
Sign in to post a comment
2
1
$Pfizer (PFE.US)$
Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease.
Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia.
Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times
Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease.
Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia.
Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times
$Eli Lilly and Co (LLY.US)$ got leaps 1400. They were cheap. kinda throwing shit and seeing what sticks. isn't fair value about 2k per share. tho.
$Novo-Nordisk A/S (NVO.US)$ over 250 this year ? leaps are cheap
$Pfizer (PFE.US)$
Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs.
Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors.
Most of the price hikes are below 10% and are to list prices, which do not i...
Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs.
Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors.
Most of the price hikes are below 10% and are to list prices, which do not i...
2
4
$Eli Lilly and Co (LLY.US)$ will it break the head / shoulder / day/ weeky play .? thoughts
2
7
14
No comment yet
HUANG AI : bull